Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04090866 · ClinicalTrials.gov registry record
Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study
A clinical trial, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- 2
- Enrollment target
NCT04090866 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 2 participants.
The verdict
NCT04090866 was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Pulmonary arterial hypertension(PAH) is associated with the development of right heart failure. In the setting of heart failure, the heart shifts to increasing dependence on glucose metabolism. In this study, the investigators will perform cardiac positron emission tomography/magnetic resonance imaging (PET/MRI) scans to measure glucose metabolism in the heart before and after initiation of pulmonary vasodilator therapy for pulmonary arterial hypertension.
Interventions
- OTHER PET/MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-11-14 |
| Est. Completion | 2020-07-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04090866
The ClinicalTrials.gov registry entry for NCT04090866 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PET/MRI is the first listed.
NCT04090866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04090866 about?
NCT04090866 is a clinical study titled "Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study". Pulmonary arterial hypertension(PAH) is associated with the development of right heart failure. In the setting of heart failure, the heart shifts to increasing dependence on glucose metabolism. In this study, the investigators will perform cardiac positron emission tomography/magnetic resonance imag...
What is the current status of trial NCT04090866?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2019-11-14. Estimated completion is 2020-07-21.
What interventions are being tested in trial NCT04090866?
The interventions under investigation include: PET/MRI (OTHER).
Who is sponsoring clinical trial NCT04090866?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.